Clinical advantages of combined seton placement and infliximab maintenance therapy for perianal fistulizing Crohn's disease: When and how were the seton drains removed?

Hepato-Gastroenterology

Volumn 57, Issue 97, 2010, Pages 3-7

  Tanaka, Shinnosuke ^a   Matsuo, Katsuichi ^a   Sasaki, Takamitsu ^a   Nakano, Masahiko ^a   Sakai, Koutarou ^a   Beppu, Richiko ^a   Yamashita, Yuichi ^a   Maeda, Kazuhiro ^a   Aoyagi, Kunihiko ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Fistulizing Crohn's disease; Infliximab; Seton

Indexed keywords

INFLIXIMAB;

ADULT; ANUS FISTULA; ARTICLE; CLINICAL ARTICLE; COLON CROHN DISEASE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; GENERAL ANESTHESIA; HUMAN; MAINTENANCE THERAPY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; PRIORITY JOURNAL; PUS; QUALITY OF LIFE; SURGICAL DRAINAGE; TREATMENT DURATION; WELLBEING;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; CROHN DISEASE; DEVICE REMOVAL; DRAINAGE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; MALE; QUALITY OF LIFE; RECTAL FISTULA; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77951981771     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Lapidus A, Bernell O, Hellers G, Lofburg R: Clinical course of colorectal Crohn's disease: a 35-year follow-up study of 507 patients. Gastroenterology 1998; 114: 1151-1160 (Pubitemid 28243900)
2. Regueiro M, Mardini H: Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm Bowel Dis. 2003; 9: 98-103 (Pubitemid 36367318)
3. Singh B, McC Mortensen NJ, Jewell DP, George B: Perianal Crohn's disease. Br J Surg. 2004; 91:801-814
4. Ingle SB, Loftus EV Jr: The natural history of perianal Crohn's disease. Dig Liver Dis. 2007; 39:963-969 (Pubitemid 47354985)
5. White RA, Eisenstat TE, Rubin RJ, Salvati EP: Seton management of complex anorectal fistulas in patients with Crohn's disease. Dis Colon Rectum 1990; 33: 587-589 (Pubitemid 20211449)
6. Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA, Podolsky DK, Sands BE, Braakman T, DeWoody KL, Schaible TF, van Deventer SJ: Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999; 340: 1398-1405
7. Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P; ACCENT I Study Group: Maintenance Infliximab for Crohn's disease: ACCENT I Randomised Trial. Lancet 2002; 359: 1541-1549
8. Rutgeerts P, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Hanauer SB: Comparison of Scheduled and Episodic Treatment Strategies of Infliximab in Crohn's disease. Gastroenterology 2004; 126: 402-413 (Pubitemid 38182297)
9. Sands BE, Anderson FH, Berstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz DR, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ: Infliximab Maintenance Therapy for Fistulizing Crohn's disease. N Engl J Med 2004; 350: 876-885
10. Sands BE, Blank MA, Patel K, van Deventer SJ: ACCENT II Study Long-term Treatment of Rectovaginal Fistulas in Crohn's disease Response to Infliximab in the ACCENT Study. Clin Gastroenterol Hepatol. 2004; 2: 912-920
11. Lichtenstein GR, Yan S, Bala M, Blank M, Sands BE: Infliximab Maintenance Treatment Reduce Hospitalizations, Surgeries, and Procedures in Fistulizing Crohn's disease. Gastroenterology 2005; 128:862-869
12. Sands BE, Blank MA, Diamond RH, Barrett JP, van Deventer SJ: Maintenance infliximab dose not result in increased abscess development in fistulizing Crohn's disease: results from the ACCENT II study. Aliment Pharmacol Ther 2006; 23: 1127-1136
13. Topstad DR, Panaccione R, Heine JA, Johnson DR, MacLean AR, Buie WD: Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience Dis Colon Rectum 2003; 46: 577-583
14. Talbot C, Sagar PM, Johnston MJ, Finan PJ, Burke D: Infliximab in the surgical management of complex fistulizing anal Crohn's disease. Colorectal Dis. 2005; 7: 164-168 (Pubitemid 40352646)
15. Tougeron D, Savoye G, Savoye-Collet C, Koning E, Micht F, Lerebours E: Predicting factors fistula healing and clinical remission after Inflizimab-based combined therapy for prerianal fistulizing Crohn's disease. Dig Dis Sci 2008; (DOI:10.1007/s10620-008-0545-y)
16. Hyder SA, Travis SP, Jewell DP, McC Mortensen NJ, George BD: Fistulizing anal Crohn's disease: results of combined surgical and infliximab treatment. Dis Colon Rectum 2006; 49: 1837-1841
17. Schnitzler F, Fidder H, Ferrante M, Noman M, Arijs I, Assche GV, Hoffman I, Steen KV, Vermeire S, Rutgeerts P: Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-center cohort. Gut 2009; 58: 492-500
18. Crohn BB, Ginzburg L, Oppenheimer GD: Regional ileitis: a pathologic and clinical entity. JAMM 1932; 99: 1323-1329
19. Bissell AD: Localized chronic ulcerative colitis. Ann Surg 1934; 99: 957-966
20. McNamara DA, Brophy S, Hyland JM: Perianal Crohn's disease and infliximab therapy. Surgeon 2004; 2: 258-263 (Pubitemid 39406269)
21. Thornton M, Solomon MJ: Long-term indwelling seton for complex anal fistulas in Crohn's disease. Dis Colon Rectum 2005; 48: 459-463 (Pubitemid 40767865)
22. Buchanan GN, Owen HA, Torkington J, Lunniss PJ, Nicholls RJ, Cohen CR: Long-term outcome following loose-seton technique for external sphincter preservation in complex anal fistula. Br J Surg 2004; 91: 476-480 (Pubitemid 38491120)
23. Osterman MT, Lichtenstein GR: Infliximab in fistulizing Crohn's disease. Gastroenterol Clin N Am 2006;35:795-820 (Pubitemid 44810889)
24. Kraemer M, Kirscmeier A, Marth T: Perioperative adjujant therapy with infliximab in complicated anal Crohn's disease. Int J Colorectal Dis 2008; 23: 965-969
25. Uza N, Nakase H, Ueno S, Inoue S, Mikami S, Tamaki H, Matsuura M, Chiba T: The effect of medical treatment on patients with fistulizing Crohn's disease: A Retrospective Study. Internal Medicine 2008; (DOI:10.2169/Internal Medicine.47.0537)
26. Spradlin NM, Wise PE, Herline AJ, Muldoon RL, Rosen M, Schwartz DA: A randomized prospective trial of endoscopic ultrasound to guide combination medical and surgical treatment for Crohn's perianal fistulas. Am J Gastroenterol 2008; 103: 2527-2535
27. Guidi L, Ratto C, Semerano S, Roberto I, De Vitis I, Papa A, Marzo M, Parello A, Foglietto G, Doglietto GB, Gasbarrini GB, Fedeli G: Combined therapy with infliximab and seton drainage for pereanal fistulizing Crohn's disease with anal endosonographic monitoring: a single-center experience. Tech Coloproctol 2008; 12: 111-117